Tenofovir and emtricitabine cerebrospinal fluid-to-plasma ratios correlate to the extent of blood-brainbarrier damage

AIDS

Volumn 25, Issue 11, 2011, Pages 1437-1439

  Calcagno, Andrea ^a,c   Bonora, Stefano ^a   Simiele, Marco ^a   Rostagno, Roberto ^a   Tettoni, Maria C ^a   Bonasso, Marino ^a   Romito, Alessandra ^b   Imperiale, Daniele ^b   D'Avolio, Antonio ^a   Di Perri, Giovanni ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b MARIA VITTORIA HOSPITAL   (Italy)

^c AMEDEO DI SAVOIA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EMTRICITABINE PLUS TENOFOVIR DISOPROXIL;

ADULT; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG PENETRATION; ENCEPHALITIS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; MALE; MEMBRANE DAMAGE; PLASMA; PRIORITY JOURNAL; VIRUS REPLICATION;

ADENINE; ADULT; BLOOD-BRAIN BARRIER; DEOXYCYTIDINE; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PHOSPHONIC ACIDS; PILOT PROJECTS;

EID: 79959919974     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3283489cb1     Document Type: Letter

References (10)

1. Canestri A, Lescure FX, Jaureguiberry S, et al. Discordance between cerebral spinal fluid and plasma HIV replication in patients with neurological symptoms who are receiving suppressive antiretroviral therapy. Clin Infect Dis 2010; 50:773-778.
2. Letendre S, C FitzSimons, R Ellis, Clifford D, Collier A, Gelman B, et al. Correlates of CSF viral load sin 1221 volunteers in the CHARTER Cohort. 17th CROI [abstract], San Francisco, CA, USA 2010; 430.
3. Dall'asta LM, Pisarov LA, Esplen JE, et al. Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 enecephalitis. Am J Pathol 1999; 155:1915-1927.
4. Abdulle S, Hagberg L, Gisslèn M. Effects of antiretroviral treatment on blood-brain barrier integrity and intrathecal immunoglobulin production in neuroasymptomatic HIV-1-infected patients. HIV Medicine 2005; 6:164-169. (Pubitemid 40740332)
5. Marchi N, Betto G, Fazio V, Fan Q, Ghosh C, Machado A, et al. Blood-brain barrier damage and brain penetration of antiepileptic drugs: role of serum proteins and brain edema. Epilepsia 2009; 50:664-677.
6. Yilmaz A, Gisslén M, Spudich S, Lee E, Jayewardene A, Aweeka F, et al. Raltegravir cerebrospinal fluid concentrations in HIV-1 infection. PLoS One 2009; 4:e6877.
7. D'Avolio A, Sciandra M, Siccardi M, Baietto L, Gonzalez de Requena D, Bonora S, et al. A new assay based on solid-phase extraction procedure with LC-MS to measure plasmatic concentrations of tenofovir and emtricitabine in HIV infected patients. J Chromatogr Sci 2008; 46:524-528. (Pubitemid 352006451)
8. Best B, Letendre S, Koopmans P, Clifford D, Collier A, Gelman B, et al. Low tenofovir concentrations in cerebrospinal fluid. 15th Conference on Retroviruses and Opportunistic Infections [abstract]. Boston, MA, USA. 2008; 131.
9. Best B, Letendre S, Capparelli E, Ellis R, Rossi S, Koopmans P, et al. Efavirenz and Emtricitabine Concentrations consistently Exceed Wild-type IC50 in Cerebrospinal Fluid: CHARTER Findings. 16th Conference on Retroviruses and Opportunistic Infections [abstract], Montreal, Canada. 2009; 702.
10. Letendre S, Croteau D, Ellis D, Clifford D, Gelman B, Marra C et al. Lower CSAR Are Associated with Global Neurocognitive Impairment in Antiretroviral-treated People with HIV. 18th Conference on Retroviruses and Opportunistic Infections [abstract], Boston, MA, USA. 2011; 408.